AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteEpifriedelanol had inhibitory effects on adriamycin-induced cellular senescence in human fibroblasts (HDFs).
More Information Supplier PageEpifriedelanol had inhibitory effects on adriamycin-induced cellular senescence in human fibroblasts (HDFs).
More Information Supplier PageEpimedin A1, extracted from Epimedium brevicornum Maxim. dried parts on the ground.
More Information Supplier PageEpimedin A1, extracted from Epimedium brevicornum Maxim. dried parts on the ground.
More Information Supplier PageEpimedin A1, extracted from Epimedium brevicornum Maxim. dried parts on the ground.
More Information Supplier PageEpirubicin is a cell-permeable antitumor antibiotic. A stereoisomer of Doxorubicin that exhibits reduced cardiotoxicity. Epirubicin?€?s antitumor actions are mediated by targeting and inhibiting Topo II (topoisomerase II).
More Information Supplier PageEpirubicin is a cell-permeable antitumor antibiotic. A stereoisomer of Doxorubicin that exhibits reduced cardiotoxicity. Epirubicin?€?s antitumor actions are mediated by targeting and inhibiting Topo II (topoisomerase II).
More Information Supplier PageEpirubicin is a cell-permeable antitumor antibiotic. A stereoisomer of Doxorubicin that exhibits reduced cardiotoxicity. Epirubicin?€?s antitumor actions are mediated by targeting and inhibiting Topo II (topoisomerase II).
More Information Supplier PageEpirubicin is a cell-permeable antitumor antibiotic. A stereoisomer of Doxorubicin that exhibits reduced cardiotoxicity. Epirubicin?€?s antitumor actions are mediated by targeting and inhibiting Topo II (topoisomerase II).
More Information Supplier PageEpirubicin is a cell-permeable anthracycline antitumor antibiotic. It is a stereoisomer(4?€?-epi-isomer) of doxorubicin that exhibits reduced cardiotoxicity. It is used to inhibit topoisomerase II and DNA helicase activity.
More Information Supplier PageEpirubicin is a cell-permeable anthracycline antitumor antibiotic. It is a stereoisomer(4?€?-epi-isomer) of doxorubicin that exhibits reduced cardiotoxicity. It is used to inhibit topoisomerase II and DNA helicase activity.
More Information Supplier PageEpirubicin is a cell-permeable anthracycline antitumor antibiotic. It is a stereoisomer(4?€?-epi-isomer) of doxorubicin that exhibits reduced cardiotoxicity. It is used to inhibit topoisomerase II and DNA helicase activity.
More Information Supplier PageEpirubicin is a cell-permeable anthracycline antitumor antibiotic. It is a stereoisomer(4?€?-epi-isomer) of doxorubicin that exhibits reduced cardiotoxicity. It is used to inhibit topoisomerase II and DNA helicase activity.
More Information Supplier PageEpirubicin is a cell-permeable anthracycline antitumor antibiotic. It is a stereoisomer(4?€?-epi-isomer) of doxorubicin that exhibits reduced cardiotoxicity. It is used to inhibit topoisomerase II and DNA helicase activity.
More Information Supplier PageEpisilvestrol is a derivative of Silvestrol, which can induce apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7; 5’myc-UTR-LUC inhibtior (IC50= 0.8 nM).
More Information Supplier PageEpisilvestrol is a derivative of Silvestrol, which can induce apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7; 5’myc-UTR-LUC inhibtior (IC50= 0.8 nM).
More Information Supplier PageEpothilone A acts by stabilising microtubule formation at the taxol binding site and causes cell cycle arrest at the G2/M transition, leading to cytotoxicity.
More Information Supplier PageEpothilone A acts by stabilising microtubule formation at the taxol binding site and causes cell cycle arrest at the G2/M transition, leading to cytotoxicity.
More Information Supplier PageEpothilone A acts by stabilising microtubule formation at the taxol binding site and causes cell cycle arrest at the G2/M transition, leading to cytotoxicity.
More Information Supplier PageEpothilone A acts by stabilising microtubule formation at the taxol binding site and causes cell cycle arrest at the G2/M transition, leading to cytotoxicity.
More Information Supplier PageEpothilone A acts by stabilising microtubule formation at the taxol binding site and causes cell cycle arrest at the G2/M transition, leading to cytotoxicity.
More Information Supplier PageEpothilone B is a macrolide that causes the formation of bundles of intracellular microtubules in non-mitotic cells, induces the formation of hyperstable tubulin polymers, and arrests cell cycling in mitosis.
More Information Supplier PageEpothilone B is a macrolide that causes the formation of bundles of intracellular microtubules in non-mitotic cells, induces the formation of hyperstable tubulin polymers, and arrests cell cycling in mitosis.
More Information Supplier PageEpothilone B is a macrolide that causes the formation of bundles of intracellular microtubules in non-mitotic cells, induces the formation of hyperstable tubulin polymers, and arrests cell cycling in mitosis.
More Information Supplier PageEpothilone B is a macrolide that causes the formation of bundles of intracellular microtubules in non-mitotic cells, induces the formation of hyperstable tubulin polymers, and arrests cell cycling in mitosis.
More Information Supplier PageEpothilone B is a macrolide that causes the formation of bundles of intracellular microtubules in non-mitotic cells, induces the formation of hyperstable tubulin polymers, and arrests cell cycling in mitosis.
More Information Supplier PageEpothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy.
More Information Supplier PageEpothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy.
More Information Supplier PageEpothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy.
More Information Supplier PageEpothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy.
More Information Supplier PageEpoxomicin is a potent anti-tumor agent isolated from Actinomycetes that is used as a selective and irreversible inhibitor of the 20S proteasome.
More Information Supplier PageEpoxomicin is a potent anti-tumor agent isolated from Actinomycetes that is used as a selective and irreversible inhibitor of the 20S proteasome.
More Information Supplier PageEpoxomicin is a potent anti-tumor agent isolated from Actinomycetes that is used as a selective and irreversible inhibitor of the 20S proteasome.
More Information Supplier PageEprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure.
More Information Supplier PageEprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure.
More Information Supplier PageEprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure.
More Information Supplier PageEprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure.
More Information Supplier PageEprosartan (mesylate) is a competitive AT1 receptor antagonist with IC50 values ranging from 1.4 ?€? 3.9 nM and an elimination half-life of five to seven hours.
More Information Supplier PageEprosartan (mesylate) is a competitive AT1 receptor antagonist with IC50 values ranging from 1.4 ?€? 3.9 nM and an elimination half-life of five to seven hours.
More Information Supplier PageEprosartan (mesylate) is a competitive AT1 receptor antagonist with IC50 values ranging from 1.4 ?€? 3.9 nM and an elimination half-life of five to seven hours.
More Information Supplier PageEprosartan (mesylate) is a competitive AT1 receptor antagonist with IC50 values ranging from 1.4 ?€? 3.9 nM and an elimination half-life of five to seven hours.
More Information Supplier PageEPZ-5676 is a small molecule inhibitor of histone methyltransferase with potential antineoplastic activity.
More Information Supplier PageEPZ-5676 is a small molecule inhibitor of histone methyltransferase with potential antineoplastic activity.
More Information Supplier PageEPZ-5676 is a small molecule inhibitor of histone methyltransferase with potential antineoplastic activity.
More Information Supplier PageEPZ-5676 is a small molecule inhibitor of histone methyltransferase with potential antineoplastic activity.
More Information Supplier PageEPZ-5676 is a small molecule inhibitor of histone methyltransferase with potential antineoplastic activity.
More Information Supplier PageEPZ-6438 is a potent, selective, and orally bioavailable small-molecule inhibitor of EZH2 enzymatic activity. It induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells.
More Information Supplier PageEPZ-6438 is a potent, selective, and orally bioavailable small-molecule inhibitor of EZH2 enzymatic activity. It induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells.
More Information Supplier PageEPZ-6438 is a potent, selective, and orally bioavailable small-molecule inhibitor of EZH2 enzymatic activity. It induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells.
More Information Supplier PageEPZ-6438 is a potent, selective, and orally bioavailable small-molecule inhibitor of EZH2 enzymatic activity. It induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells.
More Information Supplier Page
